Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aquila Resources Inc. stock logo
AQA
Aquila Resources
C$0.08
C$0.06
C$0.14
C$28.86MN/A120,403 shs68,000 shs
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
$1.80
$1.38
$3.66
$90.92M1.2656,165 shs10,300 shs
Fura Gems Inc. stock logo
FURA
Fura Gems
C$0.15
-3.3%
C$0.14
C$0.05
C$0.21
C$39.45M1.06128,388 shs10,000 shs
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$0.08
-0.4%
$0.12
$0.07
$1.42
$2.78M1.973.36 million shs491,539 shs
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aquila Resources Inc. stock logo
AQA
Aquila Resources
0.00%0.00%0.00%0.00%0.00%
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
0.00%0.00%0.00%0.00%+8.61%
Fura Gems Inc. stock logo
FURA
Fura Gems
0.00%0.00%0.00%0.00%0.00%
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
+1.71%-4.80%-40.03%-49.14%+7,729,900.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aquila Resources Inc. stock logo
AQA
Aquila Resources
N/AN/AN/AN/AN/AN/AN/AN/A
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
N/AN/AN/AN/AN/AN/AN/AN/A
Fura Gems Inc. stock logo
FURA
Fura Gems
N/AN/AN/AN/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aquila Resources Inc. stock logo
AQA
Aquila Resources
N/AN/AN/AN/A
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
N/AN/AN/AN/A
Fura Gems Inc. stock logo
FURA
Fura Gems
N/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/A

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aquila Resources Inc. stock logo
AQA
Aquila Resources
N/AN/AN/A15.00C($0.06) per shareN/A
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
$121.04M0.00N/A28.83$1.40 per share0.00
Fura Gems Inc. stock logo
FURA
Fura Gems
N/AN/AC$0.01 per share29.00C$0.02 per shareN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
$14.73M0.19N/AN/A$0.12 per share0.64

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aquila Resources Inc. stock logo
AQA
Aquila Resources
N/A-C$0.02N/AN/AN/AN/AN/AN/AN/A
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
-$580K-$0.01N/AN/AN/A-1.39%-5.84%-4.46%N/A
Fura Gems Inc. stock logo
FURA
Fura Gems
-C$29.04M-C$0.12N/AN/AN/A-495.84%-38.02%N/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
-$9.64M-$3.82N/A1.10N/A-65.46%-150.14%-53.48%N/A

Latest NBY, FURA, ATY, TSTR, and AQA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/26/2024Q4 2023
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A-$0.95-$0.95-$0.57N/A$3.73 million    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aquila Resources Inc. stock logo
AQA
Aquila Resources
N/AN/AN/AN/AN/A
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
N/AN/AN/AN/AN/A
Fura Gems Inc. stock logo
FURA
Fura Gems
N/AN/AN/AN/AN/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aquila Resources Inc. stock logo
AQA
Aquila Resources
N/A
0.62
0.61
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
0.04
3.69
3.69
Fura Gems Inc. stock logo
FURA
Fura Gems
1,870.18
0.26
0.12
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
N/A
1.67
1.00

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Aquila Resources Inc. stock logo
AQA
Aquila Resources
N/A
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
8.66%
Fura Gems Inc. stock logo
FURA
Fura Gems
N/A
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
23.25%

Insider Ownership

CompanyInsider Ownership
Aquila Resources Inc. stock logo
AQA
Aquila Resources
N/A
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
11.98%
Fura Gems Inc. stock logo
FURA
Fura Gems
65.00%
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
1.30%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Aquila Resources Inc. stock logo
AQA
Aquila Resources
11339.54 millionN/ANot Optionable
AcuityAds Holdings Inc. stock logo
ATY
AcuityAds
18756.83 million50.02 millionNot Optionable
Fura Gems Inc. stock logo
FURA
Fura Gems
N/A272.04 millionN/ANot Optionable
NovaBay Pharmaceuticals, Inc. stock logo
NBY
NovaBay Pharmaceuticals
2436.06 million35.59 millionNot Optionable

NBY, FURA, ATY, TSTR, and AQA Headlines

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Aquila Resources logo

Aquila Resources

TSE:AQA
Aquila Resources Inc., together with its subsidiaries, engages in the acquisition, exploration, and development of mineral properties in the United States and Canada. The company primarily explores for zinc, gold, copper, lead, silver, and nickel deposits. Its flagship property is the 100% owned Back Forty project, a development stage volcanogenic massive sulfide deposit located in Menominee County, Michigan. Aquila Resources Inc. is headquartered in Toronto, Canada.
AcuityAds logo

AcuityAds

NYSE:ATY
AcuityAds Holdings, Inc. engages in the provision of digital advertising solutions. It operates through the following geographical segments: Unites States, Canada, and Europe and Other. The company was founded by Tal Hayek, Nathan Mekuz, Rachel Kapcan, and Joe Ontman on October 9, 2009 and is headquartered in Toronto, Canada.
Fura Gems logo

Fura Gems

CVE:FURA
Fura Gems Inc., a gemstone mining and marketing company, engages in the mining, exploration and acquisition of gemstone licenses in Barbados, the British Virgin Islands, Colombia, Dubai, India, Mozambique, Madagascar, and Australia. It holds a 100% interests in four ruby licenses in the Montepuez district of Cabo Delgado province in Mozambique; and a 76% interests in the Coscuez license that covers an area of covers an area of 46 hectares in San Pablo de Borbur, Boyacá District of Colombia. The company also holds a 100% interests in two mining permits and three mining licenses in the sapphire mining project located in Queensland, Australia; and owns sapphire licenses in Madagascar. The company was formerly known as Fura Emeralds Inc. and changed its name to Fura Gems Inc. in April 2017. Fura Gems Inc. was incorporated in 2006 and is headquartered in Toronto, Canada. Fura Gems Inc. operates as a subsidiary of Lord of Seven Hills Holdings FZE.
NovaBay Pharmaceuticals logo

NovaBay Pharmaceuticals

NYSE:NBY
NovaBay Pharmaceuticals, Inc., a biopharmaceutical company, develops and sells eyecare, skincare, and wound care products in the United States and internationally. It offers Avenova Spray, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products, which are used for cleansing and irrigation as part of surgical procedures, as well as treating certain wounds, burns, ulcers, and other injuries under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through traditional and digital beauty retailers and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.